A Phase 1a Randomized, Double-blind, Placebo-controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Nezavist in Healthy Adults
Latest Information Update: 29 Nov 2024
Price :
$35 *
At a glance
- Drugs Alcohol-use disorder and depression therapeutic Lohocla Research (Primary)
- Indications Unspecified
- Focus Adverse reactions
- 15 Oct 2024 New trial record